NLM Logo

Adalimumab MeSH Descriptor Data 2022


MeSH Heading
Adalimumab
Tree Number(s)
D12.776.124.486.485.114.224.060.250
D12.776.124.790.651.114.224.060.250
D12.776.377.715.548.114.224.200.250
Unique ID
D000068879
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068879
Scope Note
A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
Entry Term(s)
Adalimumab-adbm
Adalimumab-atto
Amjevita
Cyltezo
D2E7 Antibody
Humira
Pharm Action
Tumor Necrosis Factor Inhibitors
Antirheumatic Agents
Registry Number
FYS6T7F842
See Also
Tumor Necrosis Factor-alpha
Public MeSH Note
2016; ADALIMUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2002-2015
History Note
2016 (2002)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2021/07/01
Adalimumab Preferred
Humira Narrower
Adalimumab-adbm Narrower
Amjevita Narrower
Adalimumab-atto Narrower
Cyltezo Narrower
D2E7 Antibody Narrower
page delivered in 0.161s